Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Скала за соматична осведоменост при сърдечна недостатъчност (HFSAS)× | Функционална класификация на Нюйоркската сърдечна асоциация (NYHA)× | |
|---|---|---|
| Област | Кардиология | Кардиология |
| Семейство | Process / pipeline | Process / pipeline |
| Година на възникване≠ | 2017 | 1994 |
| Създател≠ | Steven R. Steinhubl | New York Heart Association |
| Тип≠ | Self-report questionnaire | Ordinal clinician-assessment classification system |
| Основополагащ източник≠ | Steinhubl, S. R., Mehta, P. K., & Ebner, G. S. (2017). The digital health revolution and consumer empowerment. Current Cardiology Reports, 19(11), 105. link ↗ | The Criteria Committee of the New York Heart Association. (1994). Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels (9th ed.). Little, Brown and Company. link ↗ |
| Други названия≠ | HFSAS | NYHA, NYHA Class, Functional Classification |
| Свързани | 4 | 4 |
| Резюме≠ | The Heart Failure Somatic Awareness Scale (HFSAS) is a specialized measure that assesses heart failure patients' ability to recognize and accurately perceive early warning signs of disease worsening (somatic awareness), such as subtle changes in dyspnea, edema, weight, fatigue, or palpitations. Early recognition of decompensation signs enables prompt self-management action (diuretic adjustment, physician contact) and prevents costly hospitalizations. The HFSAS is essential in modern HF management, particularly with remote monitoring technologies and self-management support programs. | The New York Heart Association (NYHA) Functional Classification is a four-category ordinal system for grading heart failure severity based on the level of physical activity that precipitates dyspnea or other HF symptoms. Established by the NYHA in 1928 and refined in 1994, the NYHA classification is the oldest and most widely used functional status metric in cardiology, providing a simple, clinically intuitive framework for describing HF symptom burden, guiding treatment intensity, and predicting prognosis. |
| ScholarGateНабор от данни ↗ |
|
|